345 related articles for article (PubMed ID: 19641335)
21. [Multimodal treatment of hepatocellular carcinoma].
De Santibañes E; Mc Cormack L; Pekolj J; Mattera J; Acuña Barrios J; Aldet A; García Monaco R; Gadano A; D'Agostino D; Bonofiglio C; Ciardullo M
Acta Gastroenterol Latinoam; 2001; 31(5):367-75. PubMed ID: 11873663
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.
Alacacioglu A; Somali I; Simsek I; Astarcioglu I; Ozkan M; Camci C; Alkis N; Karaoglu A; Tarhan O; Unek T; Yilmaz U
Jpn J Clin Oncol; 2008 Oct; 38(10):683-8. PubMed ID: 18753360
[TBL] [Abstract][Full Text] [Related]
23. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
[TBL] [Abstract][Full Text] [Related]
24. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
25. Five-year survival after monotherapy for hepatocellular carcinoma in the setting of cirrhosis.
Fouzas I; Sotiropoulos GC; Sgourakis G; Drühe N; Wohlschlaeger J; Molmenti EP; Broelsch CE; Lang H
Transplant Proc; 2008 Nov; 40(9):3204-5. PubMed ID: 19010235
[TBL] [Abstract][Full Text] [Related]
26. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases.
Kumar R; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
QJM; 2008 Jun; 101(6):479-85. PubMed ID: 18440958
[TBL] [Abstract][Full Text] [Related]
28. Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries.
Wang BE; Ma WM; Sulaiman A; Noer S; Sumoharjo S; Sumarsidi D; Tandon BN; Nakao K; Mishiro S; Miyakawa Y; Akahane Y; Suzuki H
J Med Virol; 2002 Jul; 67(3):394-400. PubMed ID: 12116033
[TBL] [Abstract][Full Text] [Related]
29. Management and patient survival in hepatocellular carcinoma: does the physician's level of experience matter?
Chen TM; Chang TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e179-88. PubMed ID: 18466287
[TBL] [Abstract][Full Text] [Related]
30. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
Palmieri VO; Grattagliano I; Minerva F; Pollice S; Palasciano G; Portincasa P
J Surg Res; 2009 Dec; 157(2):199-207. PubMed ID: 19540521
[TBL] [Abstract][Full Text] [Related]
31. Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening.
Chan AC; Poon RT; Ng KK; Lo CM; Fan ST; Wong J
Ann Surg; 2008 Apr; 247(4):666-73. PubMed ID: 18362630
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis.
Montano-Loza AJ; Carpenter HA; Czaja AJ
Am J Gastroenterol; 2008 Aug; 103(8):1944-51. PubMed ID: 18564111
[TBL] [Abstract][Full Text] [Related]
33. [Nonsurgical therapy methods in hepatocellular carcinoma].
Wettstein M; Häussinger D
Praxis (Bern 1994); 2001 Jan; 90(1-2):15-20. PubMed ID: 11206095
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma--an update.
Sinha SN
P N G Med J; 1985 Jun; 28(2):83-8. PubMed ID: 2417429
[TBL] [Abstract][Full Text] [Related]
35. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
36. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
Huo TI; Huang YH; Chiang JH; Wu JC; Lee PC; Chi CW; Lee SD
Scand J Gastroenterol; 2007 Apr; 42(4):485-92. PubMed ID: 17454859
[TBL] [Abstract][Full Text] [Related]
37. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
38. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
[TBL] [Abstract][Full Text] [Related]
39. Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.
Graf H; Jüngst C; Straub G; Dogan S; Hoffmann RT; Jakobs T; Reiser M; Waggershauser T; Helmberger T; Walter A; Walli A; Seidel D; Goke B; Jüngst D
Digestion; 2008; 78(1):34-8. PubMed ID: 18797167
[TBL] [Abstract][Full Text] [Related]
40. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
